ABOUT leadXpro AG
leadXpro AG specializes in structure-based drug discovery for membrane proteins.
Membrane proteins are the most promising targets for drug discovery, yet, also the most challenging.
To unlock these targets, we bring together specialized knowledge in protein science, pioneering technologies in structural biology and expertise in ligand design and characterization. leadXpro’s research covers a range of membrane proteins, including GPCRs, ion channels, transporters and enzymes.
leadXpro acts as a contract research partner for a growing number of pharmaceutical, biotech and academic partners through a variety of services and partnership models.
See our technology platform
THERAPEUTICS
Using its unique technology platform, leadXpro is developing proprietary preclinical compounds with high efficacy and specificity.
See our pipeline
leadXpro Timeline
Latest updates about leadXpro
Colocalized targeting of TGF-beta and PD-L1 by bintrafusp alfa elicits distinct antitumor responses
In collaboration with Merck/Serono, leadXpro confirmed the colocalization aspect of the mode of action of bintrafusp alfa using Cryo-Electron Microscopy
Five Opportunities at the Interface Between Structural Biology and AI and their Impact on Drug Discovery
by Denis Bucher, Principal Scientist at leadXpro and Head of Molecular Modelling and Design
leadXpro joins the MabDesign Network
leadXpro AG is a sponsor of the MabDesign Network, which aims at structuration of the immunotherapeutics research sector.
Our partners
